Only hours before the end of the 2023 session, a proposal to make medical marijuana legal in Kentucky went through the state senate on Thursday after ten years of fruitless attempts.
In front of a bipartisan group of lawmakers and supporters on Friday morning, Governor Andy Beshear enacted the legislation, putting Kentucky among the states resolving to end the prohibition of medicinal marijuana. The initiative will be active starting in early 2025.
In two of the previous three years, House Representatives had approved a medicinal marijuana measure, which was rejected at the Senate because of insufficient support from the party’s Republican caucus. The law was introduced on the floor of the Senate this year and was successfully passed through that chamber two weeks ago.
According to Senate Bill 47, the program as well as its growers, producers, and dispensaries would be subject to oversight, operation, implementation, and control by the Family Services and Health Cabinet.
In Kentucky’s approach, patients would qualify for a medical card for marijuana if they had one of at least six medical conditions; cancer of any kind, irrespective of the stage, crippling pain, seizure disorders, stiffness, persistent nausea, and PTSD are among the qualifying illnesses.
A patient may also qualify if they have a diagnosis of a sickness or health problem and the recently formed Cannabis Center decides that usage of cannabis would be beneficial. The center may decide that the individual is likely to obtain therapeutic, medical, or palliative benefits based on research and evidence.
Individuals getting medical marijuana from a dispensary will be able to ingest it through edible items and topical applications rather than smoking it.
Representative Jason Nemes, a proponent who previously served as the primary sponsor of medicinal cannabis legislation, cautioned the committee that, through the proposed bill, patients who choose to smoke cannabis rather than consume it in other ways would be in violation of the law and may potentially lose their medicinal marijuana cards.
Representative Matt Lockett, one of the bill’s critics, argued that since the law won’t be in practice until 2025, there is still time for it to be improved and passed the following year. Opposers of the bill claimed that there aren’t enough studies demonstrating the effectiveness and security of using cannabis as medical care.
Republican lawmakers celebrated the historic significance of the occasion at the signing function on Friday morning in Rotunda. They also celebrated the reality that thousands of people who are suffering will receive assistance.
While Kentucky is celebrating the enactment of a medical marijuana law, residents can also take additional comfort from the knowledge that there are companies like India Globalization Capital Inc. (NYSE American: IGC) that are working tirelessly to develop pharmaceutical-grade medicines from a number of cannabis compounds for the treatment of ailments like chronic pain.
NOTE TO INVESTORS: The latest news and updates relating to India Globalization Capital Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.
